• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

上下法测定苯磺顺阿曲库铵用于麻醉诱导的 90%有效剂量(ED90)。

Up-down determination of the 90% effective dose (ED90) of remimazolam besylate for anesthesia induction.

机构信息

Department of Anesthesiology, Hebei Hospital of Traditional Chinese Medicine, Shijiazhuang, China.

出版信息

Ann Palliat Med. 2022 Feb;11(2):568-573. doi: 10.21037/apm-22-89.

DOI:10.21037/apm-22-89
PMID:35249335
Abstract

BACKGROUND

Remimazolam besylate for injection is a novel benzodiazepine. Reasonable selection and proper application of anesthetics is critical for patients. This study aims to determine the 90% effective dose (ED90) of remimazolam besylate for anesthesia induction in patients undergoing painless colonoscopy.

METHODS

A dose-response study was carried out in 112 patients undergoing painless colonoscopy between December 2020 and January 2021. The initial dose of remimazolam was 7.5 mg. The anesthesiologist assessed whether the depth of sedation was satisfactory according to the Modified Observer's Assessment of Alertness and Sedation (MOAA/S) scale. If the MOAA/S score of one patient was >1 point, the loading dose for the next patient was increased by 2.5 mg. If the MOAA/S score was ≤1 point, the current dose was maintained or reduced by 2.5 mg for the next patient according to a 9:1 biased coin design. The ED90 of remimazolam besylate for anesthesia induction for painless colonoscopy was calculated. The adverse events and complications of remimazolam besylate were recorded.

RESULTS

When the drug concentration was 1 mg/mL and the infusion rate was 1,000 mL/h, the ED90 of remimazolam besylate for painless colonoscopy was 11.43 mg [95% confidence interval (CI): 9.85-13.02 mg].

CONCLUSIONS

A loading dose of 12 mg remimazolam besylate for healthy adult patients undergoing painless colonoscopy can safely, effectively, and quickly induce patients to fall asleep and shorten the anesthesia induction time.

摘要

背景

苯磺酸瑞马唑仑注射液是一种新型苯二氮䓬类药物。合理选择和正确应用麻醉剂对患者至关重要。本研究旨在确定苯磺酸瑞马唑仑用于无痛结肠镜检查患者麻醉诱导的 90%有效剂量(ED90)。

方法

在 2020 年 12 月至 2021 年 1 月期间,对 112 例行无痛结肠镜检查的患者进行了剂量反应研究。苯磺酸瑞马唑仑的初始剂量为 7.5mg。麻醉师根据改良观察者警觉/镇静评分(MOAA/S)量表评估镇静深度是否满意。如果一位患者的 MOAA/S 评分大于 1 分,则为下一位患者增加 2.5mg 的负荷剂量。如果 MOAA/S 评分为 1 分或更低,则根据 9:1 偏倚硬币设计,为下一位患者维持或减少当前剂量 2.5mg。计算苯磺酸瑞马唑仑用于无痛结肠镜检查的麻醉诱导 ED90。记录苯磺酸瑞马唑仑的不良事件和并发症。

结果

当药物浓度为 1mg/ml,输注速度为 1000ml/h 时,苯磺酸瑞马唑仑用于无痛结肠镜检查的 ED90 为 11.43mg(95%置信区间:9.85-13.02mg)。

结论

健康成年患者行无痛结肠镜检查时,负荷剂量为 12mg 苯磺酸瑞马唑仑可安全、有效、快速诱导患者入睡,并缩短麻醉诱导时间。

相似文献

1
Up-down determination of the 90% effective dose (ED90) of remimazolam besylate for anesthesia induction.上下法测定苯磺顺阿曲库铵用于麻醉诱导的 90%有效剂量(ED90)。
Ann Palliat Med. 2022 Feb;11(2):568-573. doi: 10.21037/apm-22-89.
2
Effective remimazolam loading dose for adequate sedation in regional anesthesia.在区域麻醉中有效雷米唑仑负荷剂量以达到充分镇静。
Can J Anaesth. 2024 Jun;71(6):818-825. doi: 10.1007/s12630-024-02698-1. Epub 2024 Feb 20.
3
Determination of ED and ED of remimazolam besylate combined with alfentanil for adult gastroscopy: a prospective dose-finding study.测定苯磺酸瑞马唑仑联合阿芬太尼用于成人胃镜检查的 ED50 和 ED95:一项前瞻性剂量探索研究。
Braz J Anesthesiol. 2024 Jul-Aug;74(4):844518. doi: 10.1016/j.bjane.2024.844518. Epub 2024 May 23.
4
The effects of remimazolam combined with sufentanil on respiration, circulation and sedation level in patients undergoing colonoscopy.瑞马唑仑复合舒芬太尼对结肠镜检查患者呼吸、循环及镇静水平的影响。
BMC Anesthesiol. 2024 Jul 25;24(1):252. doi: 10.1186/s12871-024-02644-0.
5
The 90% effective dose (ED90) of remimazolam for inhibiting responses to the insertion of a duodenoscope during ERCP.瑞马唑仑用于抑制 ERCP 期间十二指肠镜插入反应的 90%有效剂量(ED90)。
BMC Anesthesiol. 2024 May 14;24(1):174. doi: 10.1186/s12871-024-02554-1.
6
Safety, pharmacokinetic and pharmacodynamic properties of single ascending dose and continuous infusion of remimazolam besylate in healthy Chinese volunteers.苯磺酸瑞马唑仑在健康中国志愿者中的单剂量递增和持续输注的安全性、药代动力学和药效学特性。
Eur J Clin Pharmacol. 2020 Mar;76(3):383-391. doi: 10.1007/s00228-019-02800-3. Epub 2019 Dec 23.
7
Safety and efficacy of remimazolam besylate in patients undergoing colonoscopy: A multicentre, single-blind, randomized, controlled, phase Ⅲ trial.苯磺酸瑞马唑仑在结肠镜检查患者中的安全性和有效性:一项多中心、单盲、随机、对照的Ⅲ期试验。
Front Pharmacol. 2022 Oct 5;13:900723. doi: 10.3389/fphar.2022.900723. eCollection 2022.
8
Remimazolam besylate for the sedation of postoperative patients undergoing invasive mechanical ventilation in the ICU: a prospective dose‒response study.苯磺酸瑞马唑仑用于 ICU 行有创机械通气术后患者镇静的前瞻性剂量反应研究。
Sci Rep. 2022 Nov 8;12(1):19022. doi: 10.1038/s41598-022-20946-6.
9
Comparison of bispectral index and patient state index as measures of sedation depth during surgeries using remimazolam tosilate.比较使用甲苯咪酯依托咪酯时脑电双频指数和患者状态指数作为镇静深度的测量指标在手术中的应用。
BMC Anesthesiol. 2023 Jun 15;23(1):208. doi: 10.1186/s12871-023-02172-3.
10
Effectiveness of remimazolam besylate combined with alfentanil for fiberoptic bronchoscopy with preserved spontaneous breathing: a prospective, randomized, controlled clinical trial.苯磺酸瑞马唑仑联合阿芬太尼用于保留自主呼吸纤维支气管镜检查的有效性:一项前瞻性、随机、对照临床试验。
Eur Rev Med Pharmacol Sci. 2023 Jul;27(13):6071-6080. doi: 10.26355/eurrev_202307_32961.

引用本文的文献

1
Evaluation of deep sedation effects and respiratory aspects of remimazolam besylate in elderly patients undergoing fiberoptic bronchoscopy.苯磺酸瑞马唑仑在老年纤维支气管镜检查患者中的深度镇静效果及呼吸方面的评估。
Front Med (Lausanne). 2025 Mar 28;12:1543866. doi: 10.3389/fmed.2025.1543866. eCollection 2025.
2
Dose-Response Study of Remimazolam Combined With Remifentanil for Attenuating Stress Response During Laryngeal Mask Airway Insertion in Elderly Female Patients: A Prospective Double-Blinded Study.瑞马唑仑联合瑞芬太尼减轻老年女性患者喉罩置入期间应激反应的剂量反应研究:一项前瞻性双盲研究
Drug Des Devel Ther. 2025 Mar 5;19:1575-1583. doi: 10.2147/DDDT.S494426. eCollection 2025.
3
Effect of Fentanyl on Remimazolam-Induced Sedation in Female Patients Undergoing Hysteroscopic Surgery: A Randomized Controlled Trial.
芬太尼对接受宫腔镜手术的女性患者瑞马唑仑诱导镇静的影响:一项随机对照试验
Drug Des Devel Ther. 2025 Feb 27;19:1393-1401. doi: 10.2147/DDDT.S504189. eCollection 2025.
4
The Impact of Fentanyl on the Effective Dose of Remimazolam-Induced Sedation in Elderly Female Patients: An Up-and-Down Sequential Allocation Trial.芬太尼对老年女性患者瑞马唑仑镇静诱导有效剂量的影响:一项上下序贯分配试验。
Drug Des Devel Ther. 2024 Aug 22;18:3729-3737. doi: 10.2147/DDDT.S473662. eCollection 2024.
5
The EC90 of remifentanil for inhibiting endotracheal intubation responses under anesthesia induction with ciprofol: study protocol for a dose-finding trial with the biased-coin design.瑞芬太尼用于抑制依托咪酯麻醉诱导下气管插管反应的 EC90:偏倚硬币设计剂量探索试验的研究方案。
Trials. 2024 Aug 23;25(1):558. doi: 10.1186/s13063-024-08397-y.
6
Remimazolam for sedation in gastrointestinal endoscopy: A comprehensive review.瑞马唑仑用于胃肠内镜检查镇静的综合综述。
World J Gastrointest Endosc. 2024 Jul 16;16(7):385-395. doi: 10.4253/wjge.v16.i7.385.
7
Comparison of remimazolam tosilate and propofol during induction and maintenance of general anesthesia in patients undergoing laparoscopic cholecystectomy: a prospective, single center, randomized controlled trial.瑞马唑仑甲苯磺酸盐与丙泊酚在腹腔镜胆囊切除术患者全麻诱导和维持中的比较:一项前瞻性、单中心、随机对照试验。
BMC Anesthesiol. 2024 Jul 6;24(1):226. doi: 10.1186/s12871-024-02614-6.
8
Relationship between age and remimazolam dose required for inducing loss of consciousness in older surgical patients.老年外科患者意识消失所需瑞马唑仑剂量与年龄的关系。
Front Med (Lausanne). 2024 Apr 29;11:1331103. doi: 10.3389/fmed.2024.1331103. eCollection 2024.
9
Modified Dixon sequential method to determine the effective dose of alfentanil compounded with propofol for day-case hysteroscopy.改良Dixon序贯法确定丙泊酚复合阿芬太尼用于日间宫腔镜检查的有效剂量
Ther Adv Drug Saf. 2023 Dec 6;14:20420986231214992. doi: 10.1177/20420986231214992. eCollection 2023.
10
Safety and efficacy of remimazolam for general anesthesia in elderly patients undergoing laparoscopic cholecystectomy: a randomized controlled trial.瑞米唑仑用于老年腹腔镜胆囊切除术患者全身麻醉的安全性和有效性:一项随机对照试验
Front Med (Lausanne). 2023 Nov 2;10:1265860. doi: 10.3389/fmed.2023.1265860. eCollection 2023.